Bristol Myers Squibb is a leading biopharmaceutical company headquartered in New York City. Founded in 1887, it focuses on discovering, developing, and delivering innovative medicines for serious diseases, including cancer, cardiovascular conditions, and immune disorders. The company’s portfolio includes well-known treatments such as Opdivo and Eliquis, and it operates globally with a strong emphasis on research and development in oncology, immunology, and cardiovascular health.